Literature DB >> 2765370

Changing patterns of relapse in Hodgkin's disease.

G Duchesne1, J Crow, S Ashley, M Brada, A Horwich.   

Abstract

The patterns of early and late relapses (those occurring later than 3 years after diagnosis) in 432 patients achieving complete remission after treatment for stage I and II Hodgkin's disease at the Royal Marsden Hospital between 1964 and 1983 were studied to identify factors predicting for late relapse. The incidence of early relapse has fallen progressively in recent treatment eras as staging procedures and management have improved but in contrast there has been no decrease in the risk of late relapse. The incidence of late relapse was greater in patients treated with radiotherapy rather than combined modality therapy (P less than 0.05). However, patients who were clinically staged and treated with combined modality therapy retained as high a risk of relapse between 3 and 6 years as in years 2 and 3. The risk of late relapse was also greater in patients with stage II disease and in those without B symptoms at presentation. Patients falling into the higher risk categories for late relapse require continued close follow-up beyond 3 years to monitor for possible relapse.

Entities:  

Mesh:

Year:  1989        PMID: 2765370      PMCID: PMC2247024          DOI: 10.1038/bjc.1989.257

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.

Authors:  S A Weller; E Glatstein; H S Kaplan; S A Rosenberg
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

2.  Prognostic indicators in Hodgkin's disease.

Authors:  L M Axtell; M H Myers; L H Thomas; C W Berard; A R Kagan; G R Newell
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

3.  Late relapse among patients treated for Hodgkin's disease.

Authors:  T S Herman; R T Hoppe; S S Donaldson; R S Cox; S A Rosenberg; H S Kaplan
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

4.  Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index.

Authors:  J L Haybittle; F G Hayhoe; M J Easterling; A M Jelliffe; M H Bennett; G Vaughan Hudson; B Vaughan Hudson; K A MacLennan
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

5.  Prognostic groups for management of localized Hodgkin's disease.

Authors:  S B Sutcliffe; M K Gospodarowicz; D E Bergsagel; R S Bush; R E Alison; H A Bean; T C Brown; T Chua; R M Clark; J E Curtis
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

6.  An analysis of prognostic factors in early stage Hodgkin's disease.

Authors:  A Horwich; D Easton; R Nogueira-Costa; K H Liew; M Colman; M J Peckham
Journal:  Radiother Oncol       Date:  1986-10       Impact factor: 6.280

7.  The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.

Authors:  R T Hoppe; C N Coleman; R S Cox; S A Rosenberg; H S Kaplan
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

8.  The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.

Authors:  M Tubiana; M Henry-Amar; M Hayat; M Burgers; M Qasim; R Somers; W Sizoo; E van der Schueren
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-02       Impact factor: 7.038

9.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.

Authors:  V T DeVita; R M Simon; S M Hubbard; R C Young; C W Berard; J H Moxley; E Frei; P P Carbone; G P Canellos
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

10.  Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

Authors:  S B Kaye; C A Juttner; I E Smith; A Barrett; D E Austin; M J Peckham; T J McElwain
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

View more
  2 in total

Review 1.  Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry.

Authors:  Maja Dam Andersen; Stephen Hamilton-Dutoit; Lena Modvig; Maja Vase; Ilse Christiansen; Jacob Haaber Christensen; Rasmus Bo Dahl-Sørensen; Danny Stoltenberg; Peter Kamper; Francesco d'Amore
Journal:  Br J Haematol       Date:  2022-04-08       Impact factor: 8.615

2.  Outcome of children with resistant and relapsed Hodgkin's disease.

Authors:  N D James; J E Kingston; P N Plowman; S Meller; R Pinkerton; A Barrett; R Sandland; T J McElwain; J S Malpas
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.